Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

U. Klaassen · SciRah

Researcher profile · Semantic Scholar

U. Klaassen

Share profile

U. Klaassen — researcher profile on SciRah

h-index: 16
Works: 40
Citations: 1,026

Most-cited papers

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.
J. Nabholtz, K. Gelmon, M. Bontenbal, M. Spielmann +7 more
1996Journal of Clinical Oncology400 citations
Semantic Scholar
Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
H. Weh, H. Wilke, J. Dierlamm, U. Klaassen +13 more
1994Annals of Oncology75 citations Open access
Semantic Scholar
Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer.
U. Klaassen, H. Wilke, D. Strumberg, W. Eberhardt +2 more
1996European Journal of Cancer73 citations
Semantic Scholar
Randomized Trial of Two Doses of Taxol in Metastatic Breast Cancer: An Interim Analysis
U. Klaassen, K. Diergarten, H. Dittrich, J. Kaufmann +2 more
199454 citations
Semantic Scholar
Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial
O. Kloke, U. Klaassen, C. Oberhoff, G. Hartwich +16 more
1999Breast Cancer Research and Treatment42 citations Open access
Semantic Scholar
345 A multicenter, randomized study of two schedules of paclitaxel (PTX) in patients with advanced breast cancer (ABC)
T. Peretz, A. Sulkes, P. Chollet, K. Gelmon +20 more
199539 citations
Semantic Scholar
Phase I study of a weekly 1 h infusion of paclitaxel in patients with unresectable hepatocellular carcinoma.
D. Strumberg, J. Erhard, A. Harstrick, U. Klaassen +4 more
1998European Journal of Cancer31 citations
Semantic Scholar
Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
C. Köhne, H. Wilke, H. Hecker, P. Schöffski +16 more
1995Annals of Oncology31 citations Open access
Semantic Scholar
Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer.
U. Klaassen, D. Borquez, S. Lang, C. Oberhoff +3 more
1999Oncology30 citations
Semantic Scholar
A Phase I Dose Escalation Trial of Intravenous Treosulfan in Refractory Cancer
A. Harstrick, H. Wilke, W. Eberhardt, U. Klaassen +5 more
199630 citations
Semantic Scholar
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines
U. Vanhoefer, M. Müller, R. Hilger, B. Lindtner +5 more
1999British Journal of Cancer26 citations Open access
Semantic Scholar
Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with plantinum.
A. du Bois, H. Lück, K. Buser, H. Meerpohl +5 more
1997European Journal of Cancer26 citations
Semantic Scholar
Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines.
U. Klaassen, A. Harstrick, N. Schleucher, U. Vanhoefer +3 more
1996British Journal of Cancer26 citations Open access
Semantic Scholar
Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinic.
U. Vanhoefer, N. Schleucher, U. Klaassen, Siegfried Seeber +1 more
2000Seminars in Oncology23 citations
Semantic Scholar
Phase I/II study with a weekly 24-hour infusion of 5-fluorouracil plus high-dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancer.
H. Wilke, U. Klaassen, W. Achterrath, M. Losch +7 more
1996Annals of Oncology20 citations Open access
Semantic Scholar
Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
U. Klaassen, A. Harstrick, H. Wilke, S. Seeber
1996Seminars in Oncology17 citations
Semantic Scholar
Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: results of a phase II study.
U. Klaassen, H. Wilke, A. Harstrick, C. Pari +6 more
1998Annals of Oncology16 citations Open access
Semantic Scholar
Phase II study with cisplatin and paclitaxel in combination with weekly high‐dose 24 h infusional 5‐fluorouracil/leucovorin for first‐line treatment of metastatic breast cancer
U. Klaassen, H. Wilke, Regina Weyhofen, A. Harstrick +6 more
1998Anti-Cancer Drugs15 citations
Semantic Scholar
Fluorouracil-based combinations in the treatment of metastatic breast cancer.
U. Klaassen, H. Wilke, A. Harstrick, S. Seeber
1998Oncology10 citations
Semantic Scholar
Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
U. Klaassen, H. Wilke, S. Seeber
1996Seminars in Oncology10 citations
Semantic Scholar
Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
U. Klaassen, H. Wilke, C. Pari, D. Strumberg +5 more
1995Seminars in Oncology8 citations
Semantic Scholar
Paclitaxel plus ifosfamide in advanced ovarian cancer: results of a phase I study.
U. Klaassen, A. Harstrick, D. Strumberg, H. Wilke +1 more
1998Anti-Cancer Drugs6 citations
Semantic Scholar
Infusional 5-FU, folinic acid, paclitaxel, and cisplatin for metastatic breast cancer.
U. Klaassen, H. Wilke, C. Müller, D. Borquez +5 more
1997Oncology6 citations
Semantic Scholar
360 Phase I/II study with paclitaxel in combination with weekly high dose 5-FU/Folinic acid in the treatment of metastatic breast cancer
U. Klaassen, H. Wilke, D. Strumberg, C. Pari +6 more
19956 citations
Semantic Scholar
492 Safety and efficacy of taxol® (paclitaxel) over 3 h in 306 platinum-refractory patients with ovarian cancer: Results of a German cooperative study
U. Klaassen, K. Kühndel, T. Bauknecht, H. Kühnle +16 more
19952 citations
Semantic Scholar
Role of Chemotherapy Against Micrometastatic Cancer
A. Harstrick, U. Klaassen, W. Eberhardt, S. Seeber
2004Cancer Metastasis Review1 citations
Semantic Scholar
Phase I/II trial of oral UFT/Leucovorin (LV) and paclitaxel (P) in the second line treatment of patients (PTS) with metastatic breast cancer (MBC)
U. Klaassen, S. Lang, D. Borquez, C. Oberhoff +3 more
19991 citations
Semantic Scholar
Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
U. Klaassen, H. Wilke, S. Seeber
1996The Journal of infusional chemotherapy1 citations
Semantic Scholar
732 Modulation of weekly high dose infusional 5-fluorouracil (FU) by leucovorin (LV), α-interferon (IFN) or LV plus IFN in advanced colorectal cancer. Results of a multicenter randomized trial of the AIO
C. Köhne, P. Schöffski, H. Wilke, C. Käufer +13 more
19951 citations
Semantic Scholar
1065 Results of a multimodality preoperative induction treatment program in locally advanced (LAD) NSCLC stages IIIA and IIIB
W. Eberhardt, H. Wilke, G. Stamatis, M. Stuschke +12 more
19951 citations
Semantic Scholar
Metastatic breast cancer: treatment with fluorouracil-based combinations.
U. Klaassen, S. Seeber
1997Oncology0 citations
Semantic Scholar
Emerging strategies in medical oncology: Introduction
J. Mcvie, G. Schwartsmann, D. Amadori, A. du Bois +1 more
19970 citations
Semantic Scholar
Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
U. Klaassen, H. Wilke, C. Müller, D. Borquez +2 more
1997Seminars in Oncology0 citations
Semantic Scholar
[Paclitaxel in therapy of breast carcinoma. Value and perspectives].
U. Klaassen, S. Seeber
1996Medizinische Klinik0 citations
Semantic Scholar
Sequential double cycle high dose chemotherapy and stem cell rescue for the treatment of primary high risk breast cancer stage II/III and greater than or equal to 10 lymphnodes
U. Klaassen, A. Harstrick, S. Mayer, C. Mueller +7 more
19960 citations
Semantic Scholar
86 Preliminary results of a stage oriented multimodality treatment including surgery for selected subgroups of limited disease small cell lung cancer (SCLC)
W. Eberhardt, H. Wilke, G. Stamatis, S. Kolks +11 more
19950 citations
Semantic Scholar
504 Phase I study with paclitaxel in combination with ifosfamide in pretreated patients with advanced ovarian carcinoma
U. Klaassen, A. Harstrick, Michael Stahl, W. Eberhardt +5 more
19950 citations
Semantic Scholar
380 Phase I study with weekly Paclitaxel (1h) infusion in heavily pretreated advanced breast cancer and ovarian cancer patients
U. Klaassen, H. Wilke, D. Strumberg, W. Eberhardt +2 more
19950 citations
Semantic Scholar
[Experiences with taxanes exemplified by paclitaxel (taxol) for internal medicine oncologic indications].
U. Klaassen, S. Seeber
1994Medizinische Klinik0 citations
Semantic Scholar
Metastatic Bone Marrow Involvement in Malignant Germ Cell Tumors
U. Klaassen, C. Bokemeyer, H. Illiger
19920 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Harstrick×21
Invite
A. Harstrick — researcher profile on SciRah
S. Seeber×15
Invite
S. Seeber — researcher profile on SciRah
S. Seeber×12
Invite
S. Seeber — researcher profile on SciRah
W. Eberhardt×11
Invite
W. Eberhardt — researcher profile on SciRah

×10

Invite

D. Strumberg — researcher profile on SciRah

Invite

H. Wilke — researcher profile on SciRah

Invite

M. Korn — researcher profile on SciRah

K. Diergarten×8

Invite

K. Diergarten — researcher profile on SciRah

Invite

H. Wilke — researcher profile on SciRah

Invite

H. Wilke — researcher profile on SciRah

Invite

D. Borquez — researcher profile on SciRah

Invite

R. Becher — researcher profile on SciRah